Important Safety Information

Before taking SOLTAMOX, you and your healthcare provider should talk about the possible benefits and risks.

  • The benefits and risks are different for women at high risk for breast cancer and women with breast cancer that is only inside the milk ducts (ductal carcinoma in-situ or DCIS) than for women who have been diagnosed with invasive breast cancer.
  • For most people who already have invasive breast cancer, the benefits of SOLTAMOX are greater than the risks.
  • Talk to your healthcare provider about which risks may affect you.

What is the most important information I should know about SOLTAMOX?

SOLTAMOX can cause serious side effects, including:

  • Uterine cancer. Cancer of the lining of the uterus (endometrial adenocarcinoma) or cancer of the body of the uterus (uterine sarcoma) may happen more often in women who take SOLTAMOX and can lead to death. People who take or have taken SOLTAMOX should have a gynecologic exam every year.
    SOLTAMOX can also cause other non-cancer effects on the uterus, including:

    • overgrowth of the lining of the uterus (hyperplasia) and uterine polyps
    • endometriosis
    • fibroids
    • irregular menstrual periods or no menstrual periods (amenorrhea)

Tell your healthcare provider right away if you get any of the following symptoms during or after treatment with SOLTAMOX:

    • irregular menstrual periods
    • abnormal vaginal bleeding
    • a change in your vaginal discharge
    • pelvic pain or pressure
  • Blood clots in your veins or lungs. Blood clots in your veins or lungs may happen more often in people who take SOLTAMOX and can lead to death, especially in people who take SOLTAMOX during their treatment with chemotherapy.
    Tell your healthcare provider right away if you get any of the following symptoms of a blood clot during treatment with SOLTAMOX:
    • sudden chest pain, shortness of breath, or coughing up blood
    • pain, tenderness, or swelling in one or both of your legs
  • Stroke. Stroke can cause serious problems and can lead to death. Get medical help right away if you get any of these symptoms of a stroke:
    • sudden weakness, tingling, or numbness of your face, arm or leg, especially on one side of your body
    • sudden confusion, trouble speaking or understanding
    • sudden trouble seeing in one or both eyes
    • sudden trouble walking, dizziness, loss of balance or coordination
    • sudden severe headache with no known cause

Do not take SOLTAMOX if you:

  • have had a serious allergic reaction to tamoxifen or any other ingredient in SOLTAMOX. Ask your healthcare provider if you are not sure.
  • have DCIS or a high-risk of breast cancer, and you
    • need to take the blood thinner medicine warfarin, or
    • have a history of a blood clot in your veins or lungs

Before taking SOLTAMOX, tell your healthcare provider about all of your medical conditions, including if you:

  • have uterine cancer or other problems with your uterus. See “What is the most important information I should know about SOLTAMOX?”
  • have irregular menstrual periods, no menstrual periods, or abnormal vaginal bleeding
  • have or had a blood clot in your veins or lungs
  • have had a stroke
  • are pregnant or plan to become pregnant. SOLTAMOX can harm your unborn baby. You should not become pregnant during treatment with SOLTAMOX or within 2 months after you stop taking it.
    Females who are able to become pregnant:
    • Before you start treatment with SOLTAMOX, your healthcare provider should do a pregnancy test to make sure that you are not pregnant.
    • You should use effective birth control (contraception) during treatment with SOLTAMOX and for 2 months after the last dose. Talk to your healthcare provider about birth control options that you may use during this time. You should not use hormonal contraceptives such as birth control pills, patches, implants, or IUDs that contain hormones.
    • Tell your healthcare provider right away if you become pregnant during treatment with SOLTAMOX.
  • are breastfeeding or plan to breastfeed. It is not known if SOLTAMOX passes into your breast milk. You should not breastfeed during treatment with SOLTAMOX and for 3 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of SOLTAMOX?
SOLTAMOX can cause serious side effects, including:

  • See “What is the most important information I should know about SOLTAMOX?”
  • Liver problems, including liver cancer. SOLTAMOX can cause changes in liver function blood tests, and sometimes can cause liver cancer and other serious liver problems that can lead to death. Your healthcare provider should do blood tests to check you for these problems during treatment with SOLTAMOX.
  • Other cancers.
  • High levels of calcium in the blood (hypercalcemia). People with breast cancer that has spread to their bones may develop hypercalcemia. Hypercalcemia can happen within a few weeks after you start taking SOLTAMOX. Your healthcare provider should check you for this problem. If it is severe, your healthcare provider may tell you to stop taking SOLTAMOX.
  • Decreased blood cell counts. SOLTAMOX can cause a decrease in platelet counts, red blood cell counts, and white blood cell counts that can be severe. Your healthcare provider should check your blood counts during treatment with SOLTAMOX.
  • Eye problems. SOLTAMOX can increase your chance of developing cataracts and other eye problems. Tell your healthcare provider about any changes in your vision or other eye symptoms during treatment with SOLTAMOX.

The most common side effects of SOLTAMOX include:

  • hot flashes
  • mood changes
  • vaginal discharge
  • vaginal bleeding. See “What is the most important information I should know about SOLTAMOX?”
  • nausea
  • swelling (fluid retention)

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of SOLTAMOX. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Keep SOLTAMOX and all medicines out of the reach of children.

General information about the safe and effective use of SOLTAMOX.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SOLTAMOX for a condition for which it was not prescribed. Do not give SOLTAMOX to other people, even if they have the same symptoms that you have. It may harm them. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about SOLTAMOX that is written for health professionals.

For more information please see full Prescribing Information

Related Links

What is SOLTAMOX?How should I take SOLTAMOX?How do I get SOLTAMOX?
<h2>SOLTAMOX® Important Safety Information - WARNING: UTERINE MALIGNANCIES and THROMBOEMBOLIC EVENTS</h2><span >See more</span>

WARNING: UTERINE MALIGNANCIES and THROMBOEMBOLIC EVENTS

  • Serious, life-threatening, and fatal events from use of tamoxifen include uterine malignancies, stroke, and pulmonary embolism. (5.1, 5.2)
  • Discuss risks and benefits of tamoxifen with women at high risk for breast cancer and women with ductal carcinoma in situ (DCIS) when considering tamoxifen use to reduce the risk of developing breast cancer. (5.1, 5.2)
  • For most patients already diagnosed with breast cancer, the benefits of tamoxifen outweigh its risks. (5.1, 5.2)

See full prescribing information for complete boxed warning.

SOLTAMOX® Important Safety Information

  • Tamoxifen citrate is contraindicated in patients who require concomitant warfarin therapy, or a history of deep vein thrombosis or pulmonary embolus, and in patients with known hypersensitivity to the drug or any of its ingredients.
  • Uterine malignancies: Promptly evaluate abnormal vaginal bleeding in a woman with current or past tamoxifen use.
  • Thromboembolic events: Risk increases with coadministered chemotherapy. For treatment of breast cancer, consider risks and benefits in patients with a history of thromboembolic events.
  • Embryo-fetal toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception.
  • Effects on the liver: Liver cancer and liver abnormalities, some fatal, have occurred. Perform periodic liver function testing.
  • The most common adverse reactions (≥20% incidence) associated with tamoxifen are hot flashes, mood disturbances, vaginal discharge, vaginal bleeding, nausea, and fluid retention.
  • Anastrozole and letrozole: Should not be used in combination with tamoxifen.
  • Warfarin: Do not use in patients taking tamoxifen for DCIS and for reduction in breast cancer incidence in women at high risk. Closely monitor coagulation indices for increased anticoagulant effect when used with tamoxifen for metastatic breast cancer or as adjuvant therapy.
  • Do not use tamoxifen in lactating women.
  • Verify pregnancy status of females prior to initiation of tamoxifen.
  • Advise females and males to use effective contraception.

Please see full Prescribing Information for SOLTAMOX®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.